EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieOpen Access · CC BY 4.0

Immune triggers preceding neuralgic amyotrophy

Davide Sparasci iD, Lenka Schilg-Hafer, Bettina Schreiner, Olivier Scheidegger, Anne-Kathrin Peyer, Agustina Maria Lascano iD, Alex Vicino iD, Bernhard Friedrich Décard, Pinelopi Tsouni, Andrea Monika Humm, Enea Pianezzi, Giulia Zezza und 12 weitere

European Journal of Neurology · 2024

DOI: 10.1111/ene.16462 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift European Journal of Neurology, 2024. Verfasst von Davide Sparasci und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Neurocenter of Southern Switzerland EOC, Lugano, Switzerland. Hauptthemen laut MEDLINE: Brachial Plexus Neuritis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Baasch-Medicus Stiftung, Zurich, Neuromuscular Research Association Basel, Foundation for the Advancement of Neurology, Lausanne.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and purpose Infections and vaccinations have been identified as potential immunological triggers of neuralgic amyotrophy (NA), but the exact type and frequency of the preceding agents is unknown.

Methods

This was a multicentre, prospective, observational, matched case–control study. NA was diagnosed by neuromuscular experts according to validated clinical criteria and electrodiagnostic studies. Clinical data and biological samples of NA patients were collected within 90 days from disease onset between June 2018 and December 2023. All NA patients were asked about prior infection and vaccination in the month before disease onset. Serological tests for hepatitis E virus, human immunodeficiency virus, severe acute respiratory syndrome coronavirus 2, Epstein–Barr virus, cytomegalovirus, parvovirus B19, varicella‐zoster virus, Borrelia burgdorferi , Mycoplasma pneumoniae and Bartonella henselae were performed in a central laboratory. Each case was matched with a healthy control for age, sex, place of residence and time of blood collection.

Results

Fifty‐seven patients and corresponding controls were included. The mean age was 45 years for both groups. NA onset was preceded by a symptomatic infectious trigger confirmed by microbiological tests in 15/57 (26.3%) patients. Coronavirus disease 2019 vaccination was considered a potential trigger in 7/57 (12.3%) subjects. An acute viral infection was associated with a bilateral involvement of the brachial plexus ( p = 0.003, Cramèr's V = 0.43).

Conclusions

Confirmed immune triggers (infection or vaccination) preceded disease onset in 22/57 (38.6%) NA cases. We suggest to test NA patients in the acute phase for intracellular antigens, especially in the case of concomitant bilateral involvement and hepatitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brachial Plexus NeuritisHumansFemaleMaleMiddle AgedAdultCase-Control StudiesProspective StudiesCOVID-19COVID-19 VaccinesAged

Stichwörter der Autor:innen

Parsonage–Turner syndromeimmune triggerinfectionneuralgic amyotrophyvaccination

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Department of Neurology, Neurocenter of Southern Switzerland EOC, Lugano, Switzerland.
  • Department of Neurology, Cantonal Hospital, St Gallen, Switzerland.
  • Department of Neurology, University and Hospital Zurich, Zurich, Switzerland.
  • Department of Neurology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland.
  • Department of Neurology, University Hospital and University of Basel, Basel, Switzerland.
  • Neurology Division, Department of Clinical Neuroscience, University Hospitals of Geneva and Faculty of Medicine, University of Geneva, Geneva, Switzerland.

ORCID-Profile: Davide Sparasci, Agustina Maria Lascano, Alex Vicino, Anelia Dietmann, Claudio Gobbi, Paolo Ripellino

Förderung

  • Baasch-Medicus Stiftung, Zurich
  • Neuromuscular Research Association Basel
  • Foundation for the Advancement of Neurology, Lausanne

Zitieren

APA

Sparasci, D., Schilg-Hafer, L., Schreiner, B., Scheidegger, O., Peyer, A. K., Lascano, A. M., Vicino, A., Décard, B. F., Tsouni, P., Humm, A. M., Pianezzi, E., Zezza, G., Hundsberger, T., Dietmann, A., Jung, H. H., Kuntzer, T., Wilder-Smith, E., Martinetti-Lucchini, G., Petrini, O., …, & Ripellino, P. (2024). Immune triggers preceding neuralgic amyotrophy. European Journal of Neurology. https://doi.org/10.1111/ene.16462

Vancouver

Sparasci D, Schilg-Hafer L, Schreiner B, Scheidegger O, Peyer AK, Lascano AM, et al. Immune triggers preceding neuralgic amyotrophy. European Journal of Neurology. 2024. doi:10.1111/ene.16462

BibTeX
@article{Sparasci2024,
  author = {Sparasci, Davide and Schilg-Hafer, Lenka and Schreiner, Bettina and Scheidegger, Olivier and Peyer, Anne-Kathrin and Lascano, Agustina Maria and Vicino, Alex and Décard, Bernhard Friedrich and Tsouni, Pinelopi and Humm, Andrea Monika and Pianezzi, Enea and Zezza, Giulia and Hundsberger, Thomas and Dietmann, Anelia and Jung, Hans H and Kuntzer, Thierry and Wilder-Smith, Einar and Martinetti-Lucchini, Gladys and Petrini, Orlando and Fontana, Stefano and Gowland, Peter and Niederhauser, Christoph and Gobbi, Claudio and Ripellino, Paolo},
  title = {Immune triggers preceding neuralgic amyotrophy},
  journal = {European Journal of Neurology},
  year = {2024},
  doi = {10.1111/ene.16462}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche